-
Orbit Genomics Appoints Strategic Communications and Capital Markets Leader Julie Silber to Board of Directors
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Julie Silber to its Board of Directors. Silber brings over 25 years of experience in investor relations, capital markets, corporate strategy, and board advisory, with expertise in the diagnostics and life sciences sectors to support Orbit’s next phase of growth in precision…
-
Orbit Genomics At MassChallenege Midpoint Road Show
Orbit Genomics thanks the MassChallenge community for an incredible Midpoint Road Show in Dallas last week! The energy, insight, and support from mentors and partners was invaluable—but what stood out most was the camaraderie among the cohort.We are surrounded by an inspiring group of founders who are each tackling MASSive problems in healthcare—from early cancer…
-
Orbit Genomics Named As Finalist In 2024 Pepperdine Most Fundable Companies Competition
Orbit Genomics, Inc. has been named one of the 30 finalists for the Pepperdine Most Fundable Companies Competition, chosen from over 2,300 applicants. We would like to thank Pepperdine and the judges for this competition in recognizing the company for its efforts in developing highly accurate genomics tests for oncology, cardiovascular, longevity and other indications.…